FRESENIUS MEDICAL CARE-ADR (FMS) Stock Balance Sheet
USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR
24.08 USD
+0.03 (+0.12%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 837.33M | 1.08B | 911.01M | 925.13M | |||
| Cash Equivalents | 1.26B | 342.86M | 324.43M | 362.77M | 556.52M | |||
| Marketable Securities | 556.99M | 309.36M | 153.54M | 187.83M | 136.36M | |||
| Receivables | 3.28B | 3.90B | 4.05B | 4.03B | 3.77B | |||
| Inventories | 2.09B | 2.07B | 2.18B | 2.30B | 2.04B | |||
| Other Current Assets | 649.97M | 465.69M | 918.56M | 414.02M | 541.98M | |||
| Total Current Assets | 7.82B | 7.92B | 8.70B | 8.20B | 7.97B | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.40B | 7.26B | 7.45B | 8.34B | 8.55B | |||
| Investments And Advances | 1.36B | 1.42B | 1.25B | 773.72M | 786.90M | |||
| Goodwill | 13.59B | 15.17B | 14.65B | 15.79B | 14.36B | |||
| Intangibles | 1.25B | 1.37B | 1.36B | 1.52B | 1.46B | |||
| Other Non-Current Assets | 465.52M | 427.83M | 507.53M | 1.13B | 1.24B | |||
| Total Non-Current Assets | 23.06B | 25.64B | 25.23B | 27.55B | 26.40B | |||
| TOTAL ASSETS | 30.89B | 33.57B | 33.93B | 35.75B | 34.37B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 67.49M | 2.10M | 456.90M | 669.01M | 1.26B | |||
| Current Portion Of LT Debt. | 1.07B | 1.22B | 1.10B | 1.37B | 1.33B | |||
| Accrued Expenses | N/A | 1.19B | 1.17B | 2.18B | 2.23B | |||
| Accounts Payable | 725.85M | 904.28M | 762.07M | 813.25M | 736.07M | |||
| Other Current Liabilities | 3.90B | 2.35B | 2.62B | 1.44B | 1.71B | |||
| Total Current Liabilities | 5.76B | 5.66B | 6.11B | 6.47B | 7.26B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 9.34B | 9.76B | 10.49B | 11.18B | 10.73B | |||
| Deferred Taxes/Income | 665.72M | 708.89M | 750.29M | 936.48M | 868.45M | |||
| Other Non-Current Liabilities | 1.22B | 1.67B | 1.75B | 1.73B | 1.53B | |||
| Total Non-Current Liabilities | 12.18B | 13.33B | 14.20B | 15.30B | 14.41B | |||
| TOTAL LIABILITIES | 17.94B | 18.99B | 20.31B | 21.76B | 21.67B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 11.84B | 11.27B | 10.92B | 10.71B | 10.83B | |||
| Additional Paid In Capital | 2.62B | 3.35B | 3.38B | 3.37B | 2.89B | |||
| Minority Interest | 959.61M | 1.19B | 1.21B | 1.46B | 1.28B | |||
| Common Shares | 293.41M | 293.41M | 293.41M | 293.41M | 293.00M | |||
| Treasury Stock | -148.30M | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -1.67B | -328.55M | -975.17M | -388.47M | -1.31B | |||
| Shares Outstanding | 582.30M | 589.46M | 589.46M | 589.46M | 588.64M | |||
| Tangible Book Value per Share | -6.51 | -6.69 | -8.15 | -11.32 | -10.66 | |||
| Total Shareholders' Equity | 12.95B | 14.58B | 13.62B | 13.99B | 12.70B | |||
| TOTAL LIABILITIES AND EQUITY | 30.89B | 33.57B | 33.93B | 35.75B | 34.37B | |||
| Statistics | ||||||||
| Debt/Equity | 0.73 | 0.67 | 0.80 | 0.85 | 0.94 | |||
| Current Ratio | 1.36 | 1.40 | 1.42 | 1.27 | 1.10 | |||
| Return On Assets (ROA) | 2.33% | 1.60% | 1.47% | 1.88% | 2.82% | |||
| Return On Equity (ROE) | 5.55% | 3.69% | 3.66% | 4.81% | 7.63% | |||
| Return On Invested Capital (ROIC) | 3.95% | 3.20% | 3.19% | 3.03% | 4.42% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 4.26% | 3.27% | 3.24% | 3.08% | 4.53% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 11.65% | 8.33% | 7.65% | 7.50% | 10.58% | |||
All data in EUR , ROIC based on taxRate of 0.29